Cargando…

A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles

Owing to the existence of the blood–brain barrier (BBB), most treatments cannot achieve significant effects on gliomas. In this study, synergistic multitarget Ang-TAT-Fe(3)O(4)-pDNA-(ss)373 lipid-polymer hybrid nanoparticles (LPNPs) were designed to penetrate the BBB and deliver therapeutic genes to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Lanxin, Qin, Yu, Wang, Yaxin, Liang, Yi, Zhu, Dunwan, Xiong, Wei, Li, Lu, Bao, Di, Zhang, Linhua, Jin, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057840/ https://www.ncbi.nlm.nih.gov/pubmed/35516547 http://dx.doi.org/10.1039/d0ra07161g

Ejemplares similares

Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang, Linhua, et al.
Publicado: (2015)

Specific anti‐glioma targeted‐delivery strategy of engineered small extracellular vesicles dual‐functionalised by Angiopep‐2 and TAT peptides
por: Zhu, Zhanchi, et al.
Publicado: (2022)

Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy
por: Zong, Zhenkun, et al.
Publicado: (2019)

Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review
por: Habib, Saffiya, et al.
Publicado: (2022)

Modification of graphene oxide by angiopep-2 enhances anti-glioma efficiency of the nanoscaled delivery system for doxorubicin
por: Zhao, Yue, et al.
Publicado: (2020)

Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
por: Wang, Xuan, et al.
Publicado: (2018)

Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
por: Wang, Xuan, et al.
Publicado: (2019)

Cholate-modified polymer-lipid hybrid nanoparticles for oral delivery of quercetin to potentiate the antileukemic effect
por: Yin, Juntao, et al.
Publicado: (2019)

Homogeneous antibody–angiopep 2 conjugates for effective brain targeting
por: Anami, Yasuaki, et al.
Publicado: (2022)

Angiopep-2-conjugated poly(ethylene glycol)-co- poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
por: Lu, Fei, et al.
Publicado: (2017)

Revealing Angiopep-2/LRP1 Molecular Interaction for Optimal Delivery to Glioblastoma (GBM)
por: di Polidoro, Angela Costagliola, et al.
Publicado: (2022)

Discovery and in Vivo Evaluation of Novel RGD-Modified Lipid-Polymer Hybrid Nanoparticles for Targeted Drug Delivery
por: Zhao, Yinbo, et al.
Publicado: (2014)

Transactivator of transcription (TAT) peptide– chitosan functionalized multiwalled carbon nanotubes as a potential drug delivery vehicle for cancer therapy
por: Dong, Xia, et al.
Publicado: (2015)

Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis
por: Li, Han, et al.
Publicado: (2023)

Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-cHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells
por: Costagliola di Polidoro, Angela, et al.
Publicado: (2021)

Influence of the Drug Position on Bioactivity in Angiopep-2—Daunomycin Conjugates
por: Pethő, Lilla, et al.
Publicado: (2023)

Single-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery
por: Yi, Yunfeng, et al.
Publicado: (2014)

Bromelain Loaded Lipid-Polymer Hybrid Nanoparticles for Oral Delivery: Formulation and Characterization
por: Ebrahimian, Mahboubeh, et al.
Publicado: (2022)

Hesperidin-Loaded Lipid Polymer Hybrid Nanoparticles for Topical Delivery of Bioactive Drugs
por: Jangde, Rajendra, et al.
Publicado: (2022)

Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier
por: Papademetriou, Iason, et al.
Publicado: (2018)

Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy
por: Xiang, Jing, et al.
Publicado: (2023)

Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapy
por: He, Yingna, et al.
Publicado: (2014)

MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles
por: Wu, Bo, et al.
Publicado: (2017)

Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel
por: Qin, Lu, et al.
Publicado: (2021)

Inhalable Formulation Based on Lipid–Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast
por: Craparo, Emanuela F., et al.
Publicado: (2022)

Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD
por: Liang, Jun, et al.
Publicado: (2018)

Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system
por: Dave, Vivek, et al.
Publicado: (2017)

Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
por: Tahir, Nayab, et al.
Publicado: (2019)

Delivery luteolin with folacin-modified nanoparticle for glioma therapy
por: Wu, Cong, et al.
Publicado: (2019)

Lipid–Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media
por: Kliesch, Lena, et al.
Publicado: (2022)

Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles
por: Chu, Yongchao, et al.
Publicado: (2017)

Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses
por: Wang, Nannan, et al.
Publicado: (2022)

Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
Publicado: (2020)

Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability
por: Du, Xinhui, et al.
Publicado: (2021)

Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma
por: Krishna Moorthy, Nivetha, et al.
Publicado: (2021)

Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood–brain barrier and target glioma
por: Ji, Xuemei, et al.
Publicado: (2019)

TAT-LHRH conjugated low molecular weight chitosan as a gene carrier specific for hepatocellular carcinoma cells
por: Liu, Lanxia, et al.
Publicado: (2014)

Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
por: Wang, Chengguang, et al.
Publicado: (2022)

Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery
por: Sakpakdeejaroen, Intouch, et al.
Publicado: (2022)

Selenized Polymer-Lipid Hybrid Nanoparticles for Oral Delivery of Tripterine with Ameliorative Oral Anti-Enteritis Activity and Bioavailability
por: Ren, Yuehong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vbvpbclnbt076jqr3ldon0t71f